Literature DB >> 22500874

Breast and cervical cancer in 187 countries between 1980 and 2010.

J Ferlay, D Forman, C D Mathers, F Bray.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22500874     DOI： 10.1016/S0140-6736(12)60595-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

1.  Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.

Authors:  Jun Xu; Ling Xu; Baohua Yang; Lifeng Wang; Xiao Lin; Hong Tu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Twist-related protein 1-mediated regulation of mesenchymal change contributes to the migration and invasion of cervical cancer cells.

Authors:  Danqing Wang; Qingli Li; Kemin Li; Ping Xiao; Rutie Yin
Journal:  Oncol Lett       Date:  2015-08-27       Impact factor: 2.967

3.  Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells.

Authors:  Sianadh Dunn; Olivia Lombardi; Radoslaw Lukoszek; Victoria H Cowling
Journal:  Open Biol       Date:  2019-04-26       Impact factor: 6.411

4.  History, biology, and health inequities: emergent embodied phenotypes and the illustrative case of the breast cancer estrogen receptor.

Authors:  Nancy Krieger
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

Review 5.  Who and what is a "population"? Historical debates, current controversies, and implications for understanding "population health" and rectifying health inequities.

Authors:  Nancy Krieger
Journal:  Milbank Q       Date:  2012-12       Impact factor: 4.911

6.  Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.

Authors:  Soni Kumari; Shyam Babu Prasad; Suresh Singh Yadav; Mohan Kumar; A Khanna; V K Dixit; Gopal Nath; Sunita Singh; Gopeshwar Narayan
Journal:  Med Oncol       Date:  2016-03-31       Impact factor: 3.064

7.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study.

Authors:  Melina Arnold; Nirmala Pandeya; Graham Byrnes; Prof Andrew G Renehan; Gretchen A Stevens; Prof Majid Ezzati; Jacques Ferlay; J Jaime Miranda; Isabelle Romieu; Rajesh Dikshit; David Forman; Isabelle Soerjomataram
Journal:  Lancet Oncol       Date:  2014-11-26       Impact factor: 41.316

8.  MET receptor is a potential therapeutic target in high grade cervical cancer.

Authors:  Katarzyna Miekus; Marta Pawlowska; Małgorzata Sekuła; Grazyna Drabik; Zbigniew Madeja; Dariusz Adamek; Marcin Majka
Journal:  Oncotarget       Date:  2015-04-30

9.  Therapeutic Touch Has Significant Effects on Mouse Breast Cancer Metastasis and Immune Responses but Not Primary Tumor Size.

Authors:  Gloria Gronowicz; Eric R Secor; John R Flynn; Evan R Jellison; Liisa T Kuhn
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-31       Impact factor: 2.629

10.  Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.

Authors:  Timothy R Rebbeck; Susan S Devesa; Bao-Li Chang; Clareann H Bunker; Iona Cheng; Kathleen Cooney; Rosalind Eeles; Pedro Fernandez; Veda N Giri; Serigne M Gueye; Christopher A Haiman; Brian E Henderson; Chris F Heyns; Jennifer J Hu; Sue Ann Ingles; William Isaacs; Mohamed Jalloh; Esther M John; Adam S Kibel; Lacreis R Kidd; Penelope Layne; Robin J Leach; Christine Neslund-Dudas; Michael N Okobia; Elaine A Ostrander; Jong Y Park; Alan L Patrick; Catherine M Phelan; Camille Ragin; Robin A Roberts; Benjamin A Rybicki; Janet L Stanford; Sara Strom; Ian M Thompson; John Witte; Jianfeng Xu; Edward Yeboah; Ann W Hsing; Charnita M Zeigler-Johnson
Journal:  Prostate Cancer       Date:  2013-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.